drugset / Trial / NCT00000354

Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 3

NCT00000354

Treatment

Summary

The purpose of this study is to determine the safety of lofexidine in the treatment of opiate withdrawal. Preliminary data will also be obtained to assess the ability of lofexidine to alleviate opiate withdrawal signs and symptoms.

Timeline

Start
1996-07
Primary completion
1997-09
Completion
1997-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Lofexidine Small molecule

Indications